India, June 16 -- Intelligent Bio Solutions Inc. (INBS), a medical technology company, on Tuesday announced initiation of a clinical study to support a 510(k) clearance from the U.S. Food and Drug Administration (FDA) its Fingerprint Drug Screening system for the opiate codeine.
The system involves a portable mechanism to hygienically screen fingerprint sweat to determine presence of opiate drugs. The device can be utilized for quick and precise drug screening in workplaces to check for recent drug use, as results are reportedly provided within 10 minutes.
The company has partnered with CenExel Clinical Research Inc. to conduct a clinical and interference study. The study will establish the precision of the test in identifying codeine res...